Weiwei Du

771 total citations
16 papers, 580 citations indexed

About

Weiwei Du is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Weiwei Du has authored 16 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Neurology. Recurrent topics in Weiwei Du's work include Epigenetics and DNA Methylation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Myasthenia Gravis and Thymoma (2 papers). Weiwei Du is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Myasthenia Gravis and Thymoma (2 papers). Weiwei Du collaborates with scholars based in China, Hong Kong and United States. Weiwei Du's co-authors include Xiang Cheng, Zhaoliang Chen, Yan Zhang, Xiangdong He, Wei He, Xuean Mo, Jinpin Li, Jingli Liu, Yanfang Tao and Jian Pan and has published in prestigious journals such as Blood, Genetics and Cellular and Molecular Life Sciences.

In The Last Decade

Weiwei Du

16 papers receiving 575 citations

Peers

Weiwei Du
Comparison fields: 5 of 82
  • Molecular Biology 299
  • Oncology 144
  • Immunology 115
  • Pulmonary and Respiratory Medicine 99
  • Cancer Research 89
Replace Karine Laud with:
Karine Laud France
Erik R. Olson United States
Shan Zhao China
Yan Yin China
Lu Zhao China
Yong Tang China
Chandran S. Abhinand India
Seung Baek Lee South Korea
Xiaoming Huang China
Kenneth Cheung Hong Kong
Karine Laud France View profile →
Citations per field, relative to Weiwei Du
Weiwei Du · 1×
Citations per year, relative to Weiwei Du
Weiwei Du · 1×

Countries citing papers authored by Weiwei Du

Since Specialization
Citations

This map shows the geographic impact of Weiwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Du more than expected).

Fields of papers citing papers by Weiwei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Du. The network helps show where Weiwei Du may publish in the future.

Co-authorship network of co-authors of Weiwei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Du. A scholar is included among the top collaborators of Weiwei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Du. Weiwei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
# Work Indexed citations
1 34
2
Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers.
2
3 5
4 1
5 33
6 13
7 116
8 18
9 216
10 17
11 33
12 30
13
A novel sphingosine kinase 1 inhibitor (SKI-5C) induces cell death of Wilms' tumor cells in vitro and in vivo.
11
14 23
15 1
16 27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026